BIONTECH SE

BNTX
Delayed Quote. Delayed  - 11/26 01:00:00 pm
348USD +14.19%

Turn to zoom
Prev.348.0000
Open337.4300
High372.4900
Low335.0353
Volume11 028 954
Latest news
4h ago
4h ago
6h ago
7h ago
Chart BIONTECH SE
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishNeutralBullish
Resistance353447389
Spread/Res.-1,4%-22%-11%
Spread/Supp.27%71%89%
Support274204184
Financials
Sales 2021 17 474 M 19 776 M 19 776 M
Net income 2021 9 220 M 10 434 M 10 434 M
Net cash 2021 9 793 M 11 083 M 11 083 M
P/E ratio 2021 8,37x
Yield 2021 -
Capitalization 74 268 M 84 049 M 84 049 M
EV / Sales 2021 3,69x
EV / Sales 2022 3,18x
Nbr of Employees 2 800
Free-Float 87,3%
Company
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including...

>> Read more
Sector :
Bio Therapeutic Drugs
Calendar :
2021-11-30 Presentation
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 15
Last Close Price 307,50 €
Average target price 259,68 €
Spread / Average Target -15,6%